These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12201846)

  • 21. The clinical significance of anti-"Mi(a)".
    Feng CS
    Transfusion; 1994; 34(11):1013-4. PubMed ID: 7974697
    [No Abstract]   [Full Text] [Related]  

  • 22. Does an alloimmune response to strong immunogenic red blood cell antigens enhance a response to weaker antigens?
    Schonewille H; Brand A
    Transfusion; 2008 May; 48(5):958-63. PubMed ID: 18454736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Miltenberger subsystem of the MNSs blood group system. Review and outlook.
    Dahr W
    Vox Sang; 1992; 62(3):129-35. PubMed ID: 1609514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ADCC (K-cell) lysis of human erythrocytes sensitized with rhesus alloantibodies. III. Comparison of IgG anti-D agglutinating and lytic (ADCC) activity and the role of IgG subclasses.
    Urbaniak SJ; Greiss MA
    Br J Haematol; 1980 Nov; 46(3):447-53. PubMed ID: 6778497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An isotopic antiglobulin test for quantitation of anti-sheep red blood cell antibodies of individual Ig classes in mice bearing different IgCH haplotypes.
    Haber J; Winn HJ
    J Immunol Methods; 1982; 48(1):61-74. PubMed ID: 6173443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allo-anti-M: Detection peaks around 2 years of age, but may be attenuated by red blood cell transfusion.
    Tamai Y; Ohto H; Yasuda H; Takeshita A; Fujii N; Ogo H; Yazawa Y; Hato T; Mitani K; Suzuki K; Yokohama A; Kato Y; Abe M; Kumagawa M; Ueda Y; Nollet KE; Cooling L; Kitazawa J;
    Transfusion; 2021 Sep; 61(9):2718-2726. PubMed ID: 34287925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical and serological analyses of 70 erythrocyte allo-antibodies to MNS blood group system].
    Wu BT; Yao DG; Rong RM
    Zhonghua Yi Xue Za Zhi; 2013 Feb; 93(8):592-3. PubMed ID: 23663338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful transfusion of antigen positive blood to alloimmunised patients using a monocyte monolayer assay.
    Noumsi GT; Billingsley KL; Moulds JM
    Transfus Med; 2015 Apr; 25(2):92-100. PubMed ID: 25828731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and specificity of red-blood-cell antibodies in a multiethnic South and East Asian patient population and influence of using novel MUT+Mur+ kodecytes on its detection.
    Nadarajan VS; Laing AA; Saad SM; Usin M
    Vox Sang; 2012 Jan; 102(1):65-71. PubMed ID: 21592136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An alloantibody to a high-prevalence MNS antigen in a person with a GP.JL/Mk phenotype.
    Ratliff J; Veneman S; Ward J; Lomas-Francis C; Hue-Roye K; Velliquette RW; Sausais L; Maldonado T; Miyamoto J; Martin Y; Slater D; Reid ME
    Immunohematology; 2007; 23(4):146-9. PubMed ID: 18284304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibodies that define NANA-independent MN-system antigens.
    Judd WJ; Issitt PD; Pavone BG; Anderson J; Aminoff D
    Transfusion; 1979; 19(1):12-8. PubMed ID: 432908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoglobulin G subclasses and isoimmunized pregnancy outcome.
    Taslimi MM; Sibai BM; Mason JM; Dacus JV
    Am J Obstet Gynecol; 1986 Jun; 154(6):1327-32. PubMed ID: 3717242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production of allo-anti-Ena by an individual whose red blood cells carry some Ena antigen.
    Issitt PD; Wilkinson-Kroovand S; Langley JW; Smith N
    Transfusion; 1981; 21(2):211-4. PubMed ID: 7222203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Further examples of human anti-Me found in sera of Israeli donors.
    Levene C; Sela R; Lacser M; BarShany S; Giles CM; Poole J
    Vox Sang; 1984; 46(4):207-10. PubMed ID: 6710971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunohematologic study and transfusion approach to patients with public antibodies].
    Solves P; de la Rubia J; Arriaga F; Cervera J; Arnao M; Carpio N; Marty ML
    Sangre (Barc); 1997 Feb; 42(1):25-9. PubMed ID: 9229799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and clinical significances of red cell alloimmunization and red cell bound immunoglobulin G in polytransfused patients with thalassemias.
    Thedsawad A; Taka O; Wanachiwanawin W
    Hematology; 2019 Dec; 24(1):208-214. PubMed ID: 30479186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Red-cell alloantibody response in AIDS.
    Ramsey G; Stoler M; Blumberg N
    Lancet; 1983 Sep; 2(8349):575. PubMed ID: 6136730
    [No Abstract]   [Full Text] [Related]  

  • 38. First case of haemolytic disease of the newborn due to anti-Mur in Hong Kong.
    Lin CK; Mak KH; Szeto SC; Poon KH; Yuen CM; Chan NK; Liu HW; Ng CP
    Clin Lab Haematol; 1996 Mar; 18(1):19-22. PubMed ID: 9118598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RBC alloimmunization and double alloantibodies in thalassemic patients.
    Azarkeivan A; Ahmadi MH; Zolfaghari S; Shaiegan M; Ferdowsi S; Rezaei N; Lotfi P
    Hematology; 2015 May; 20(4):223-7. PubMed ID: 25130935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Prevalence of Red Blood Cell Alloantibodies in Lower Northern Thailand.
    Po-ngernnak P; Sasjeenpong S; Chuesakul K; Pangwangthong K
    J Med Assoc Thai; 2016 Dec; 99(12):1337-43. PubMed ID: 29952524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.